Ajax-Loading

Merck & Company Inc - Current Deferred Revenue

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Current-Deferred-Revenue" stands at 4.33 Billion United States Dollars as of 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.23 percent compared to the value the year prior.
The 1 year change in percent is 12.23.
The 3 year change in percent is 353.88.
The 10 year change in percent is -68.07.

The Serie's long term average value is 4.47 Billion United States Dollars. It's latest available value, on 09/30/2024, is 3.18 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2021, to it's latest available value, on 09/30/2024, is +353.88%.
The Serie's change in percent from it's maximum value, on 09/30/2014, to it's latest available value, on 09/30/2024, is -68.07%.

Current Deferred Revenue for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Current Deferred Revenue905,699,262,464.00
LogoJohnson & Johnson - Current Deferred Revenue486,508,953,600.00
LogoAbbVie Inc - Current Deferred Revenue399,570,305,024.00
LogoRoche Holding AG - Current Deferred Revenue317,433,206,677.55
LogoAstraZeneca PLC - Current Deferred Revenue280,205,508,085.11